Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of the trial is to compare the glycaemic control, measured as HbA1c after 52 weeks of treatment, in patients with type 2 diabetes treated with a supplementary insulin therapy (SIT+) being randomized either to a SIT+ fixed dose regimen or to a SIT+ flexible dose regimen including more intensive education and therapy control.
Inclusion criteria
- type II diabetes mellitus